4//SEC Filing
Ricks David A 4
Accession 0000059478-25-000216
CIK 0000059478other
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 4:23 PM ET
Size
8.7 KB
Accession
0000059478-25-000216
Insider Transaction Report
Form 4
Ricks David A
SVP and Pres, Lilly Bio-Meds
Transactions
- Purchase
Common Stock
2025-08-12$644.77/sh+1,632$1,052,263→ 546,601.167 total
Holdings
- 54,117(indirect: By David A. Ricks 2022 GRAT)
Common Stock
- 68,656(indirect: By David A. Ricks SLAT)
Common Stock
- 300(indirect: By Trust)
Common Stock
- 7,295.84(indirect: By 401(k))
Common Stock
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $644.45 to $645.11, inclusive. The reporting person undertakes to provide to Eli Lilly and Company, any security holder of Eli Lilly and Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]Includes 16 shares previously held in a family member's retirement account.
- [F3]On May 15, 2025, 5,340 shares of Eli Lilly and Company common stock were transferred to the reporting person as an annuity payment in accordance with the terms of the Grantor Retained Annuity Trust, of which the reporting person is the trustee.
- [F4]The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Documents
Issuer
ELI LILLY & Co
CIK 0000059478
Entity typeother
Related Parties
1- filerCIK 0001538604
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 4:23 PM ET
- Size
- 8.7 KB